Back to Search
Start Over
Infliximab De-escalation in Patients With Crohn’s Disease in Clinical Remission Is Safe and Well-tolerated
- Source :
- Inflammatory Bowel Diseases. 27:2031-2033
- Publication Year :
- 2021
- Publisher :
- Oxford University Press (OUP), 2021.
- Subjects :
- Crohn's disease
medicine.medical_specialty
business.industry
Remission Induction
Gastroenterology
Antibodies, Monoclonal
medicine.disease
Inflammatory bowel disease
Infliximab
Treatment Outcome
Crohn Disease
Gastrointestinal Agents
Internal medicine
medicine
Humans
Immunology and Allergy
In patient
business
De-escalation
medicine.drug
Subjects
Details
- ISSN :
- 15364844 and 10780998
- Volume :
- 27
- Database :
- OpenAIRE
- Journal :
- Inflammatory Bowel Diseases
- Accession number :
- edsair.doi.dedup.....9a61222ebc1f1dd3f3d4fc875cd6cfaa